The utility of a telemedicine platform to monitor adherence and adverse effects of tyrosine kinase inhibitors

Tyrosine kinase inhibitors (TKIs), like imatinib, have radically changed the treatment of chronic myeloid leukemia (CML) since the early 2000s. Most CML patients will need prolonged treatment with ...